학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 110건 | 목록 1~20
Academic Journal
Ahmad, S S, Crittenden, M R, Tran, P T, Kluetz, P G, Blumenthal, G M, Bulbeck, H, Baird, R D, Williams, K J, Illidge, T, Hahn, S M, Lawrence, T S, Spears, P A, Walker, A J & Sharma, R A 2018, 'Clinical Development of Novel Drug-Radiotherapy Combinations', Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-18-2466
Academic Journal
Chang E; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pelosof L; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Lemery S; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Gong Y; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Goldberg KB; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Farrell AT; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Keegan P; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Veeraraghavan J; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Wei G; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Amiri-Kordestani L; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Singh H; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Fashoyin-Aje L; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Gormley N; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Kluetz PG; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pazdur R; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Beaver JA; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Theoret MR; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Forde PM; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, MD.; Bonomi P; Section of Medical Oncology, Rush Medical Center, Chicago, IL.; Shaw A; Thoracic Cancer Program, Massachusetts General Hospital, Boston, MA.; Blumenthal GM; FDA's Oncology Center of Excellence, United Stated Food and Drug Administration, Silver Spring, MD.; Ferris A; LUNGevity Foundation, Bethesda, MD.; Patel C; FDA's Oncology Center of Excellence, United Stated Food and Drug Administration, Silver Spring, MD.; Melemed A; Clinical Research Department, Eli-Lilly and Company, Indianapolis, IN.; Basu Roy U; LUNGevity Foundation, Bethesda, MD.; Ramamoorthy A; Office of Clinical Pharmacology, United Stated Food and Drug Administration, Silver Spring, MD.; Liu Q; Office of Clinical Pharmacology, United Stated Food and Drug Administration, Silver Spring, MD.; Burns T; Division of Hematology/ Oncology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA.; Gainor JF; Thoracic Cancer Program, Massachusetts General Hospital, Boston, MA.; Lovly C; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN.; Piotrowska Z; Thoracic Cancer Program, Massachusetts General Hospital, Boston, MA.; Lehman J; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN.; Selig W; WSCollaborative, McLean, VA. Electronic address: wendy@wscollaborative.com.
Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Academic Journal
Febbo PG; Illumina, San Diego, California, USA.; Martin AM; Novartis Pharmaceuticals, East Hanover, New Jersey, USA.; Scher HI; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Barrett JC; AstraZeneca, Waltham, Massachusetts, USA.; Beaver JA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Springs, Maryland, USA.; Beresford PJ; Biodesix, Inc, Boulder, Colorado, USA.; Blumenthal GM; AstraZeneca, Waltham, Massachusetts, USA.; Bramlett K; Thermo Fisher Scientific, Austin, Texas, USA.; Compton C; College of American Pathologists, Scottsdale, Arizona, USA.; Dittamore R; Epic Sciences, San Diego, California, USA.; Eberhard DA; Illumina, San Diego, California, USA.; Edelstein D; Sysmex Inostics, Baltimore, Maryland, USA.; Godsey J; Illumina, San Diego, California, USA.; Gruen A; Seven Bridges Genomics, Boston, Massachusetts, USA.; Hanlon SE; Office of the Director, National Cancer Institute, Bethesda, Maryland, USA.; Hicks J; University of Southern California, Los Angeles, California, USA.; Hovelson D; University of Michigan, Ann Arbor, Michigan, USA.; Hullings M; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Johann D; University of Arkansas, Little Rock, Arkansas, USA.; Johnson J; AstraZeneca, Waltham, Massachusetts, USA.; Kolatkar A; University of Southern California, Los Angeles, California, USA.; Kuhn P; University of Southern California, Los Angeles, California, USA.; Levine R; Prostate Cancer Foundation, Los Angeles, California, USA.; Martini JF; Pfizer, San Diego, California, USA.; Miller DP; Center for Translational Data Science, University of Chicago, Chicago, Illinois, USA.; Moore C; Streck, Inc., La Vista, Nebraska, USA.; Moy B; Seven Bridges Genomics, Boston, Massachusetts, USA.; Pathak A; Center for Device and Radiological Health, US Food and Drug Administration, Silver Springs, Maryland, USA.; Philip R; Center for Device and Radiological Health, US Food and Drug Administration, Silver Springs, Maryland, USA.; Reese D; Provista Diagnostics Inc, New York, New York, USA.; Royalty W; Streck, Inc., La Vista, Nebraska, USA.; Ryder M; Sysmex Inostics, Baltimore, Maryland, USA.; Sakul H; Pfizer, San Diego, California, USA.; Salvatore LM; Open Commons Consortium, Chicago, Illinois, USA.; Schade A; Eli Lilly and Company, Indianapolis, Indiana, USA.; Silvestro A; Novartis Pharmaceuticals, Cambridge, Massachusetts, USA.; Simmons JK; Personal Genome Diagnostics, Baltimore, Maryland, USA.; Simons J; Prostate Cancer Foundation, Los Angeles, California, USA.; Singh Bhan S; Foundation Medicine, Cambridge, Massachusetts, USA.; Smalley MD; CytoLumina, Inc, Los Angeles, California, USA.; Somiari SB; CSSIMMW (Windber Research Institute), Windber, Pennsylvania, USA.; Talasaz A; Guardant Health, Inc, Redwood City, California, USA.; Tewari M; University of Michigan, Ann Arbor, Michigan, USA.; Tseng HR; CytoLumina, Inc, Los Angeles, California, USA.; Vinson J; Prostate Cancer Clinical Trials Consortium, New York, New York, USA.; Wells W; Open Commons Consortium, Chicago, Illinois, USA.; Welsh A; Foundation Medicine, Cambridge, Massachusetts, USA.; Grossman RL; Center for Translational Data Science, University of Chicago, Chicago, Illinois, USA.; Lee JSH; University of Southern California, Los Angeles, California, USA.; Leiman LC; BloodPAC, Chicago, Illinois, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Kim J; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Nair A; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Keegan P; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Beaver JA; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Kluetz PG; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Chuk M; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Schneider JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Miklos AC; Office of Program Planning, Analysis, and Evaluation, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland, USA.; Onken J; Research Enterprise Analytics, LLC, Rockville, Maryland, USA.; Gong Y; Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Calcagno AM; Office of Program Planning, Analysis, and Evaluation, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland, USA.; Blumenthal GM; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Aragon R; Office of Program Planning, Analysis, and Evaluation, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland, USA.; Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Tsui DWY; Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center.; Blumenthal GM; Oncology Center of Excellence, Food and Drug Administration.; Philip R; Division of Molecular Genetics and Pathology, CDRH, Food and Drug Administration.; Barrett JC; Vice President, Oncology Translational Medicine, AstraZeneca.; Montagut C; Head of Gastrointestinal Cancer from Hospital Del Mar-IMIM, CIBERONC, Barcelona, Spain.; Bramlett K; Director, R&D, Life Sciences Group, Thermo Fisher Scientific.; Ladanyi M; Chief, Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center.; Ghosh S; Chief, Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE
Academic Journal
Przepiorka D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Luo L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Subramaniam S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Qiu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Gudi R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Cunningham LC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Nie L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Leong R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Ma L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Sheth C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Deisseroth A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pazdur R; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Komiya T; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA takefumi.komiya@parkview.com.; Parkview Cancer Institute, Wayne, Indiana, USA.; Blumenthal GM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; DeChowdhury R; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Fioravanti S; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Ballas MS; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; GlaxoSmithKline, Philadelphia, Pennsylvania, USA.; Morris J; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; University of Cincinnati, Cincinnati, Ohio, USA.; Hornyak TJ; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; VA Medical Center, Baltimore, Maryland, USA.; Wank S; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Hewitt SM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Morrow B; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Memmott RM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Rajan A; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Dennis PA; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; AstraZeneca, Gaithersburg, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Richardson NC; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA nicholas.richardson@fda.hhs.gov.; Kasamon YL; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Chen H; Office of Biostatistics, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; de Claro RA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Ye J; Office of Biostatistics, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Blumenthal GM; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Farrell AT; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Pazdur R; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Morcos PN; Clinical Pharmacology, Pharmaceutical Sciences, Pharma Research and Early Development (pRED), Roche Innovation Center, New York, New York, USA.; Liu J; Office of Clinical Pharmacology, Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; Office of Hematology and Oncology Products, Food and Drug Administration, Silver Spring, Maryland, USA.; Zhao H; Office of Clinical Pharmacology, Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Sissung TM; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.; Rajan A; Thoracic and Gastrointestinal Oncology Branch, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.; Blumenthal GM; Thoracic and Gastrointestinal Oncology Branch, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.; Liewehr DJ; Biostatistics and Data Management Section, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.; Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.; Berman A; Office of Research Nursing in the Office of the Clinical Director, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, United States of America.; Giaccone G; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C., United States of America.; Figg WD; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, Maryland, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Schuck RN; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Woodcock J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Zineh I; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Stein P; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Jarow J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Temple R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Permutt T; Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; LaVange L; Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Beaver JA; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Charlab R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Dorff SE; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Leptak C; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Lemery S; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Rogers H; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Chowdhury B; Office of New Drugs, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Litwack ED; Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pacanowski M; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Odogwu L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA lauretta.odogwu@fda.hhs.gov.; Mathieu L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Goldberg KB; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Blumenthal GM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Larkins E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Rodriguez L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Bijwaard K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Lee EY; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Philip R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Fan I; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Donoghue M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Keegan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; McKee A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Blumenthal, Gideon M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어